Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

21 Jul 2020

CEPI extends funding call to accelerate development and global manufacture of COVID-19 vaccines
The extended Call for Proposals, supported by the European Commission, invites applications from vaccine developers to accelerate vaccine development and ensure that manufacturing capacity will meet global demand as quickly as possible.

Read more

Read article

15 Jul 2020

More than 150 countries engaged in COVID-19 Vaccine Global Access Facility
Interest from governments represents more than 60% of the world’s population.

Read more

13 Jul 2020

University of Queensland vaccine becomes seventh CEPI-supported COVID-19 vaccine candidate to enter clinical trials
The first participants were today enrolled into a Phase 1 clinical trial of the University of Queensland’s candidate vaccine.

Read more

09 Jul 2020

Nominations open for experts to join COVAX group advising on COVID-19 vaccine candidates
COVAX, one of the four ACT Accelerator Pillars, is setting up an Independent Product Group to advise on COVID-19 vaccine candidates. Deadline for nominations to join Friday 17 July.

Read more

07 Jul 2020

CEPI expands partnership with Clover Biopharmaceuticals to rapidly advance development and manufacture of COVID-19 vaccine candidate
Funding will support clinical development in parallel with scale-up of manufacturing capacity to potentially produce hundreds of millions of doses per year.

Read more

02 Jul 2020

Austria donates €2 million to CEPI to support COVID-19 vaccine programmes
The Government of Austria's funding will support CEPI's urgent work to advance the development of COVID-19 vaccines.

Read more

26 Jun 2020

COVAX: ensuring fair allocation of a COVID-19 vaccine
A global initiative to ensure equitable access to COVID-19 vaccines for all countries

Read more

25 Jun 2020

Stevanato Group signs an agreement with CEPI to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development
This supply is part of CEPI’s efforts to rapidly speed up the vaccine development timeline through making progress on manufacturing in parallel with the clinical development of COVID-19 candidate vaccines.

Read more

Read article

23 Jun 2020

CEPI-funded COVID-19 vaccine candidates progress to clinical trials
Clover Biopharmaceuticals have started Phase 1 trials of its COVID-19 candidate vaccine. CureVac and the University of Queensland are also set to begin clinical trials shortly.

Read more

09 Jun 2020

Greece announces $1.6 million funding to CEPI to support COVID-19 vaccine development
The donation, first announced by Prime Minister of Greece Kyriakos Mitsotakis on 4 May, will contribute to CEPI’s efforts to advance the development of a safe, effective and globally accessible vaccine against COVID-19.

Read more

05 Jun 2020

The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
CEPI and CSL will fund the development and manufacture of UQ’s “molecular clamp” enabled vaccine against COVID-19. 

Read more

©2020 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.